2.56 USD
↘ 0.02 (0.78%)AT CLOSE (03:59 PM EDT)
CytomX Therapeutics, Inc.
CTMXNASDAQ • USD
2.58
↗ 0.02 (0.59%)
POST MARKET (AS OF 05:19 PM EDT)
Post Market
AS OF 05:19 PM EDT
2.58
↗ 0.02 (0.59%)
Market: OPEN
CytomX Therapeutics, Inc. (CTMX) is currently trading at $2.58. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, CTMX trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Oct 6, 2026.
Open?$2.61
High?$2.63
Low?$2.51
Prev. Close?$2.58
Volume?2.0M
Avg. Volume?3.9M
VWAP?$2.57
Rel. Volume?0.50x
Bid / Ask
Bid?$2.52 × 700
Ask?$2.62 × 700
Spread?$0.10
Midpoint?$2.57
Valuation & Ratios
Market Cap?562.2M
Shares Out?217.9M
Float?200.3M
Float %?91.9%
P/E Ratio?N/A
P/B Ratio?1.86
EPS?-$0.38
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
Address
151 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
Phone: 650.515.3185
SOUTH SAN FRANCISCO, CA 94080
Phone: 650.515.3185
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?30
Momentum?10
Short Sent.?15
Piotroski F-Score?1/9Weak
Altman Z-Score?1.85Grey
Confidence?72%Moderate
Short InterestHigh
Short % of Float?19.29%High
Short Interest?38.6M
Days to Cover?9.3
Free Float200.3M
Avg Daily Volume4.2M
Settlement Date2026-09-15
Financial Health
Current Ratio?9.36Strong
Quick Ratio?9.36Strong
Cash Ratio?0.43Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.86CHEAP▾
Peers100
S&P78
P/S?30.72HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-6.3CHEAP▾
S&P97
EV/Sales?29.78HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-27.4%WEAK▾
S&P6
ROA?-21.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-82482000
Enterprise Value?$545.0M
Fundamentals ratios updated end of day